Results 81 to 90 of about 6,051 (258)

Reducing carbon footprint of metered-dose inhalers

open access: yes, 2022
Fluorinated propellants used in asthma inhalers have global warming potential in excess of 1400 kg CO2 equivalent. Hence, these propellants must be replaced with low-global warming potential alternatives for environmental and economic reasons.
Swetha Chowdary Vutlapalli (13108260)
core   +1 more source

Cyanogenic Compounds, Physicochemical Parameters and Metals in Water From Cassava Processing Areas: A Study in the Brazilian Amazon, Using Multivariate Analysis

open access: yesEnvironmental Toxicology, EarlyView.
ABSTRACT This study evaluated the water quality of artesian wells and effluents generated in cassava processing in a rural area of Bragança, Pará, with emphasis on physicochemical parameters, multielement composition, and cyanogenic compounds. The well water presented specific nonconformities, highlighting pH values below the recommended level and high
Alana Coêlho Maciel   +13 more
wiley   +1 more source

Comparing the effects of face-to-face and video-based education on inhaler use: A randomized, two-group pretest/posttest study

open access: yesIranian Journal of Nursing and Midwifery Research, 2018
Background: The quality of inhaler use can significantly affect the effectiveness of inhalation medications. This study was done to compare the effects of face-to-face and video-based education methods on inhaler use.
Mohsen Adib-Hajbaghery, Zeynab Karimi
doaj   +1 more source

Microplastics and the Endocrine–Metabolic Interface: Novel Diagnostic Tools Targeting Thyroid–Adipose Axis

open access: yesEnvironmental Toxicology, EarlyView.
ABSTRACT Microplastics (MPs) have been identified as major environmental contaminants that can affect organisms directly and act as carriers of particles and chemical additives, thereby aggravating endocrine networks that coordinate metabolic homeostasis.
Sunday Amos Onikanni   +10 more
wiley   +1 more source

Development of Respimat® Soft Mist™ Inhaler and its clinical utility in respiratory disorders

open access: yesMedical Devices: Evidence and Research, 2011
Richard N Dalby1, Joachim Eicher2, Bernd Zierenberg21Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD, USA; 2Boehringer Ingelheim, Ingelheim, GermanyAbstract: The Respimat® Soft Mist™ Inhaler (SMI ...
Dalby RN, Eicher J, Zierenberg B
doaj  

Quantitative Dual‐Energy CT Perfusion Versus SPECT/CT V/Q Scintigraphy for Preoperative Lung Function Assessment: A Prospective Cohort Study

open access: yesJournal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Accurate preoperative physiological assessment is critical for high‐risk patients undergoing lung resection to predict postoperative lung function. This study compared quantitative dual‐energy CT (DECT) perfusion with SPECT/CT for lobar perfusion mapping in an at‐risk oncological cohort.
Jack Edward Liu   +6 more
wiley   +1 more source

Avanços na inaloterapia em pediatria Advances in inhalation therapy in pediatrics

open access: yesJornal de Pediatria, 2010
OBJETIVOS: Revisar os artigos mais relevantes a respeito dos aspectos técnicos da terapêutica inalatória, dos inaladores disponíveis e principalmente dos principais avanços obtidos na inaloterapia em pediatria.
Fábio Pereira Muchão   +1 more
doaj   +1 more source

Cautionary Tales for Science‐Based Policy in Deep‐Sea Mining Governance

open access: yesGlobal Policy, EarlyView.
ABSTRACT This article examines how low‐certainty scientific claims permeate high‐stakes policy debates before rigorous validation. Using deep‐sea mining governance as a focal domain, the study traces high‐visibility narratives, including the “dark oxygen” hypothesis, radioactive risks of polymetallic nodules, projected impacts of sediment plume ...
Lucía Villar‐Muñoz
wiley   +1 more source

QUALITY RISK MANAGEMENT FOR SALBUTAMOL PRESSURIZED METERED DOSE INHALERS

open access: yesРазработка и регистрация лекарственных средств, 2019
The risks for the functional characteristics of Salbutamol pressurized metered dose inhaler (pMDI), such as the uniformity of delivered dose, the distribution of salbutamol particles at the stages of the Andersen impactor (apparatus D), and the ...
N. A. Lyapunov   +5 more
doaj  

Beyond abstinence: Redefining success in cannabis use disorder treatment

open access: yesAddiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy